je.st
news
NuPathe shares soar on news of competing bid
2014-01-09 02:36:00| Biotech - Topix.net
NuPathe said in a Securities and Exchange Commission filing that Israel's Teva Pharmaceutical Industries Ltd. wants to buy the company for $3.65 in cash for each NuPathe share, plus up to $3.15 per share in payments if NuPathe's migraine treatment patch Zecuity reaches certain sales milestones.
Tags: news
bid
shares
competing
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||